(Q41441746)

30 September 2017

title

The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma (English)

1 reference

30 September 2017

1 reference

Bin Zhang

1

1 reference

30 September 2017

Bin Song

2

1 reference

30 September 2017

Xin Wang

3

1 reference

30 September 2017

Xu-Sheng Chang

4

1 reference

30 September 2017

Tao Pang

5

1 reference

30 September 2017

Xin Zhang

6

1 reference

30 September 2017

Kai Yin

7

1 reference

30 September 2017

Guo-En Fang

8

1 reference

30 September 2017

publication date

13 February 2015

1 reference

30 September 2017

1 reference

30 September 2017

volume

36

1 reference

30 September 2017

issue

7

1 reference

30 September 2017

page(s)

5459-5466

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3212-x

30 September 2017

exact match

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

CD39 and CD73 in immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

CD73: a potent suppressor of antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Immunity, inflammation and cancer: a leading role for adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Purinergic signalling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

High expression of CD73 as a poor prognostic biomarker in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Ensemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Colorectal cancer: a tale of two sides or a continuum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Immune escape mechanisms in colorectal cancer pathogenesis and liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3212-X

Activities of adenosine deaminase and 5'-nucleotidase in cancerous and noncancerous human colorectal tissues

21 January 2018

1 reference

12 December 2020

High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients

1 reference

12 December 2020

The roles of CD73 in cancer

1 reference

12 December 2020

Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.

1 reference

12 December 2020

Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion

1 reference

12 December 2020

10.1007/S13277-015-3212-X

Identifiers

DOI

1 reference

Dimensions Publication ID

30 September 2017

1043622590

0 references

1 reference